½ÃÀ庸°í¼­
»óǰÄÚµå
1519504

¼¼°èÀÇ ¾î·¹ÀÌ Àåºñ ½ÃÀå º¸°í¼­ : ¿ëµµ, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Array Instruments Market Report by Application, Technology, End-User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¾î·¹ÀÌ Àåºñ ½ÃÀå ±Ô¸ð´Â 2023³â 11¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. IMARC GroupÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 16¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2024-2032³â°£ 3.6%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

¾î·¹ÀÌ Àåºñ´Â ½ÇÇè½Ç¿¡¼­ ¿©·¯ À¯ÀüÀÚÀÇ ¹ßÇöÀ» Á¤·®ÀûÀ¸·Î µ¿½Ã¿¡ ¸ð´ÏÅ͸µÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¾î·¹ÀÌ ÀåÄ¡¿¡´Â ¼ö¹é °³ÀÇ ¼­·Î ´Ù¸¥ »ç·Ê¿¡¼­ äÃëÇÑ ´Ù¼öÀÇ ÀÛÀº ´ëÇ¥ Á¶Á÷ »ùÇÃÀÌ Æ÷ÇԵǾî ÀÖÀ¸¸ç, ÇϳªÀÇ Á¶Á÷ÇÐ ½½¶óÀ̵忡 ¼öÁýµË´Ï´Ù. ¾î·¹ÀÌ ÀåºñÀÇ °í¼º´É Á¢±Ù ¹æ½ÄÀº À¯ÀüÀÚÇü¿¡¼­ ¿°»öü ¹ßÇö°ú µ¹¿¬º¯À̸¦ ã¾Æ³»°í, ¸Þ½ÅÀú RNA(mRNA) ¹× ´Ü¹éÁú ¼öÁØ¿¡¼­ À¯ÀüÀÚ ¹ßÇöÀ» ÃøÁ¤ÇÏ°í °ËÃâÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ±× °á°ú ºÐÀÚ»ý¹°ÇÐ, ¼¼Æ÷»ý¹°ÇÐ, À¯ÀüÇÐ, ºÐÀÚº´¸®ÇÐ, ÇÙ»ê ÇÕ¼º ¹× ¿°±â¼­¿­ ºÐ¼® µî¿¡ ÀÀ¿ëµÇ°í ÀÖ½À´Ï´Ù.

¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Á¶±â ¹ß°ß ¹× Áø´ÜÀÇ Çʿ伺 Áõ°¡´Â Àü ¼¼°è ¾î·¹ÀÌ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ¿Í ´õºÒ¾î ¿©·¯ ±¹°¡ÀÇ Á¤ºÎ°¡ ÀÇ·á ½Ã¼³ °³¼±¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, À̴ ƯÈ÷ ½ÅÈï °æÁ¦±¹¿¡¼­ ¾î·¹ÀÌ Àåºñ ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ Àåºñ´Â ´Ù¾çÇÑ ±â¼ú°ú °áÇÕÇÒ ¼ö Àֱ⠶§¹®¿¡ »ý¸í°úÇÐ ¹× ½Å¾à°³¹ß°ú °°Àº ´Ù¾çÇÑ ¿¬±¸ ºÎ¹®¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, µ¥¿Á½Ã¸®º¸ÇÙ»ê(DNA) ¸¶ÀÌÅ©·Î¾î·¹ÀÌ´Â »óº¸Àû DNAÀÇ Çü±¤ Ç¥ÁöÈ­¸¦ ÅëÇØ À¯ÀüÀÚ ¹ßÇö º¯È­¸¦ Á¶»çÇÏ´Â µ¥ »ç¿ëµÇ¸ç, Á¶Á÷ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ´Â Àΰ£¿¡¼­ »õ·Î¿î Áø´Ü ¹× ¿¹ÈÄ ¸¶Ä¿¸¦ ½Äº°ÇÏ°í ¾ÏÀ» Ç¥ÀûÀ¸·Î »ï´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ ¿Ü¿¡µµ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¹Ý ºñ±³À¯ÀüüÇÏÀ̺긮µ¥À̼Ç(Array CGH)°ú °°Àº ÷´Ü ±â¼úÀÇ Ã¤ÅÃÀº ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®µé

  • ¼¼°è ¾î·¹ÀÌ Àåºñ ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ¼ºÀåÇØ¿Ô°í, ¾ÕÀ¸·Î ¾î¶»°Ô ¼ºÀåÇÒ °ÍÀΰ¡?
  • ÁÖ¿ä Áö¿ª ½ÃÀåÀº ¾îµðÀΰ¡?
  • Äڷγª19°¡ ¼¼°è ¾î·¹ÀÌ Àåºñ ½ÃÀå¿¡ ¹ÌÄ£ ¿µÇâÀº?
  • ¿ëµµº° ½ÃÀå ºÐ¼®Àº ¹«¾ùÀΰ¡?
  • ±â¼úº° ½ÃÀå ÇöȲÀº ¾î¶»°Ô µÇ³ª¿ä?
  • ¾î·¹ÀÌ Àåºñ ½ÃÀå »ê¾÷ÀÇ °¡Ä¡»ç½½¿¡¼­ °¢ ´Ü°è´Â?
  • ¾î·¹ÀÌ Àåºñ ½ÃÀå »ê¾÷ÀÇ ÁÖ¿ä ÃËÁø¿äÀΰú °úÁ¦´Â?
  • ¾î·¹ÀÌ Àåºñ ½ÃÀå »ê¾÷ÀÇ ¼¼°è ±¸Á¶¿Í ÁÖ¿ä ÁøÃâ±â¾÷Àº?
  • ¾î·¹ÀÌ Àåºñ ½ÃÀå »ê¾÷ÀÇ °æÀï Á¤µµ´Â ¾î´À Á¤µµÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ Á¢±Ù
    • Åé´Ù¿î Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ¾î·¹ÀÌ Àåºñ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ºÐÀÚ»ý¹°ÇÐ
  • ¼¼Æ÷»ý¹°ÇÐ
  • À¯ÀüÇÐ
  • ºÐÀÚ º´¸®ÇÐ
  • ±âŸ

Á¦7Àå ½ÃÀå ºÐ¼® : ±â¼úº°

  • DNA ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • ´Ü¹éÁú ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • ¼¼Æ÷ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • Á¶Á÷ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿¬±¸°³¹ß¼Ò
  • ÀÓ»ó Áø´Ü ½ÇÇè½Ç
  • ³ó¾÷ ¿¬±¸¼¾ÅÍ
  • ¼öÀÇÇÐ ¿¬±¸¼Ò
  • ¹ýÀÇÇм¾ÅÍ
  • ±âŸ

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå PorterÀÇ »ê¾÷ ºÐ¼®

  • °³¿ä
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ÁöÇ¥

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Affymetrix Inc.
    • Agilent Technologies Inc.
    • Arrayit Corporation
    • Bio-RAD Laboratories Inc.
    • Illumina Inc.
    • Laboratory Corporation
    • Molecular Devices LLC
    • Raybiotech Inc.
    • Sigma Aldrich Corporation
    • Thermo Fisher Scientific Inc.

The global array instruments market size reached US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1.6 Billion by 2032, exhibiting a growth rate (CAGR) of 3.6% during 2024-2032.

An array instrument is used in laboratories for quantitatively and simultaneously monitoring the expression of multiple genes. It contains numerous small representative tissue samples from hundreds of different cases, which are assembled on a single histologic slide. The high-throughput approach of the array instrument aids in locating chromosomal expressions and mutations in a genotype, as well as measuring and detecting gene expressions at the messenger RNA (mRNA) or protein level. As a result, it finds applications in molecular and cell biology, genetics, molecular pathology, and for synthesizing and sequencing nucleic acids.

The increasing prevalence of chronic diseases, in confluence with the emerging need for their early detection and diagnosis, represents one of the key factors driving the global array instruments market growth. In addition to this, governments of several countries are investing in the improvement of healthcare facilities, which in turn, is positively influencing the demand for array instruments, especially in emerging economies. Furthermore, these instruments can be incorporated with a wide range of technologies, owing to which they find applications in different areas of research, such as life sciences and drug discovery. For instance, deoxyribonucleic acid (DNA) microarrays are used for examining changes in gene expression by fluorescent labeling of complementary DNA, whereas tissue microarrays aid in identifying new diagnostic and prognostic markers and targeting cancer in human beings. Other than this, the introduction of advanced technologies, such as microarray-based comparative genomic hybridization (array CGH), is expected to bolster the market growth in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global array instruments market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application, technology and end-user.

Breakup by Application:

Molecular Biology

Cell Biology

Genetics

Molecular Pathology

Others

Breakup by Technology:

DNA Microarrays

Protein Microarrays

Cellular Microarrays

Tissue Microarrays

Breakup by End-User:

Research and Development Laboratories

Clinical Diagnostic Labs

Agriculture Research Centers

Veterinary Laboratories

Forensic Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Affymetrix Inc., Agilent Technologies Inc., Arrayit Corporation, Bio-RAD Laboratories, Inc. Illumina Inc., Laboratory Corporation, Molecular Devices LLC, Raybiotech Inc., Sigma Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global array instruments market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global array instruments market?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global array instruments market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Array Instruments Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Molecular Biology
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cell Biology
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Genetics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Molecular Pathology
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 DNA Microarrays
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Protein Microarrays
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cellular Microarrays
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Tissue Microarrays
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Research and Development Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinical Diagnostic Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Agriculture Research Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Veterinary Laboratories
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Forensic Centers
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Affymetrix Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Arrayit Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Bio-RAD Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Illumina Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Laboratory Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Molecular Devices LLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Raybiotech Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sigma Aldrich Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦